|
|
|
|
| Discover available CDMO capacity for critical fill/finish services, including sterile filling, lyophilization, and advanced packaging, at the Fill/Finish session of the Outsourced Pharma Capacity Update (Oct. 10). This virtual event highlights technologies and quality standards essential for safe, effective biopharmaceutical delivery. Engage in short, interactive presentations and connect with CDMOs ready to support your manufacturing needs. Open to biopharma companies, consultants, and investors seeking trusted partners for late-stage production. Save your spot today! |
|
|
|
|
By Drug Delivery Leader: Supplier Horizons | Chief Scientific Officer Geraldine Venthoye from Phillips Medisize joins Supplier Horizons host Tom von Gunden in a conversation about advancements in inhalation and injection for targeting a broader range of patient needs. The two discuss formulation and delivery system challenges for complex, large molecule biologics, including vaccines, immunotherapies, and cell and gene therapies. | |
|
|
FDA URRA Guidance: Use-Related Risk Analysis In Device Development | By Fran DeGrazio, executive editor, Drug Delivery Leader | The FDA draft guidance on Use-Related Risk Analysis (URRA) clarified key considerations regarding the identification and mitigation of potential hazards in biopharmaceutical product use. In this article, Fran DeGrazio comments on the guidance. |
|
|
|
|
|
|
|
|
|
|
| Join over 1,000 pharma, biotech and drug delivery experts at the 15th Annual PODD: Partnership Opportunities in Drug Delivery Conference, October 27–28, 2025, in Boston, MA. Featuring 10 focused tech tracks and a partnering app for 1:1 meetings, you’ll assess delivery needs, explore partnership opportunities and stay at the forefront of cutting-edge delivery solutions. Use code DDL20 for a 20% discount off registration. |
|
|
|
|
|
|